Aardvark Therapeutics, Inc. - 8-K Filing
David (Zhongwei) Zhang appointed as Class II director of Aardvark Therapeutics, effective October 7, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $AARD